Table 1 Baseline demographic data of subjects with and without cardiac or metabolic syndrome X
|
CSX (−) MetX (−) (N = 39) |
CSX (+) MetX (−) (N = 35) |
CSX (−) MetX (+) (N = 15) |
CSX (+) MetX (+) (N = 24) | p a | p b | |
|---|---|---|---|---|---|---|
| Gender (M/F) | 25/14 | 25/10 | 8/7 | 14/10 | 0.593 | |
| Age (years) | 59 (49, 68) | 56 (50, 65) | 54 (46, 61) | 55 (50, 66) | 0.638 | 0.655 |
| Hypertension (N) (%) | 8 (20.5 %) | 15 (42.9 %) | 9 (60 %) | 22 (91.7 %) | <0.001 | |
| Body mass index (kg/m2) | 23.8 (22.4, 26.0) | 25.2 (23.9, 27.6) | 28.6 (25.5, 31.5) | 27.7 (24.6, 30.8) | <0.001 | <0.001 |
| Current smoking (N) (%) | 2 (5.1 %) | 6 (17.1 %) | 4 (26.7 %) | 9 (37.5 %) | 0.012 | |
| Total cholesterol (mg/dL) | 151 (134, 170) | 164 (146, 193) | 166 (135, 196) | 185 (159, 211) | 0.004 | <0.001 |
| Calculated LDL-C (mg/dL) | 83 (74, 104) | 96 (83, 120) | 93 (67, 106) | 97 (76, 134) | 0.105 | 0.057 |
| HDL-C (mg/dL) | 48 (41, 60) | 51 (46, 56) | 42 (36, 44) | 43 (38, 48) | <0.001 | 0.015 |
| Triglycerides (mg/dL) | 86 (51, 115) | 83 (64, 113) | 156 (116, 192) | 203 (145, 240) | <0.001 | <0.001 |
| Fasting plasma glucose (mg/dL) | 94 (88, 112) | 95 (89, 113) | 110 (102, 126) | 106 (93, 128) | 0.012 | 0.015 |
| Fasting serum insulin (µIU/mL) | 4.5 (2.9, 9.9) | 8.4 (4.9, 10.6) | 9.2 (5.9, 16.7) | 9.4 (5.1, 19.9) | 0.022 | 0.012 |
| Hs-CRP (mg/dL) | 0.127 (0.057, 0.344) | 0.079 (0.036, 0.297) | 0.220 (0.152, 0.530) | 0.138 (0.082, 0.318) | 0.180 | 0.661 |
| Medication use | ||||||
| Use of statin (N) (%) | 3 (7.7 %) | 2 (5.7 %) | 0 | 3 (12.5 %) | 0.506 | |
| Use of ACEI or ARB (N) (%) | 12 (30.8 %) | 7 (20 %) | 3 (20 %) | 10 (41.7 %) | 0.270 | |
